Objective: This study is to determine the effect of the natural product parthenolide, a sesquiterpene lactone isolated from extracts of the herb Tanacetum parthenium, on the proliferation of vascular smooth muscle cells (VSMCs). Methods: Rat aortic VSMCs were isolated and cultured in vitro, and treated with different concentrations of parthenolide (10, 20 and 30 μmol/L).
INTRODUCTION
The proliferation of vascular smooth muscle cells (VSMCs) is a central event during the pathogenesis of vascular lesions, including postangioplasty restenosis, transplant arteriosclerosis and vein graft occlusion (Rivard and Andres, 2000; Hedin et al., 2004) . Identification of novel drugs that may inhibit the proliferation of VSMCs has become an area of great interest in both research and clinical settings (Spyridopoulos and Andres, 1998; Weissberg et al., 1993) . The natural product parthenolide, a sesquiterpene lactone isolated from extracts of the Mexican-Indian medicinal herb Tanacetum parthenium, has been commonly used for the treatment of various infectious and inflammatory conditions such as arthritis, asthma and migraines for many years . Furthermore, an increasing number of studies have indicated that parthenolide could inhibit tumor growth (Oka et al., 2007; Ross et al., 1999) , exert beneficial effects in myocardial reperfusion injury , and interfere with a number of cellular processes including oxidative phosphorylation, platelet aggregation, and histamine and serotonin release, as well as neutrophil chemotaxis (Groenewegen and Heptinstall, 1990; Sheehan et al., 2002) . Parthenolide has also been found to inhibit activation of transcription factor nuclear factor-κB (NF-κB) Sheehan et al., 2002; Hehner et al., 1998; .
In this study, we determined the effects of parthenolide on the proliferation and cell cycle dynamics of rat aortic VSMCs. Moreover, the regulatory effects of parthenolide on p21 and p27 were also examined, since p21 and p27 are two important members of Cip/Kip family that negatively regulates G 1 /S phase and inhibits cell proliferation (Maddika et al., 2007; Hengst and Reed, 1998) . Previous studies have shown that alpha inhibitor of nuclear factor-κB (IκBα) may mediate the anti-inflammatory effect of parthenolide Hehner et al., 1998; and that cyclooxygenase-2 (Cox-2) is regulated by NF-κB (Dubois et al., 1998; Moon et al., 2004) . Both IκBα and Cox-2 may play roles in VSMC proliferation (Young et al., 2000; Tzeng et al., 2007) ; therefore, the effects of parthenolide on these two molecules were also investigated.
MATERIALS AND METHODS

Cell culture
Rat aortic smooth muscle cells were isolated from the thoracic aorta of 2-to 3-month-old Harlan Sprague-Dawley rats by using the explant technique according to a modified method . Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) and 1% (v/v) penicillin/streptomycin. The purity of VSMCs was evaluated by morphology and immunocytochemistry staining with monoclonal antibodies against α-smooth muscle actin (SM-α actin). Prior to the experimental treatments, cells were grown to ~80% confluency followed by incubation with serum-free medium for 24 h to make cells quiescent. VSMCs from passages 4~6 were used in this study. 
Reagents
Flow cytometric analysis
Cell cycle progression and distribution were determined by flow cytometric analysis. After serum starvation for 24 h, cells were stimulated with different concentrations of parthenolide (10, 20 and 30 μmol/L) in medium supplemented with 10% FBS for 24 h. At the end of time-point, all the cells were harvested by trypsinization, washed with ice-cold PBS, and fixed in 70% ice-cold ethanol diluted in PBS. Around 1×10 5 VSMCs were incubated in PBS containing 100 g/ml RNase and 40 g/ml propidium iodide at room temperature for 0.5~1.0 h before flow cytometry analysis. Cell cycle distribution and DNA content were determined by using a Berkman Coulter cytometer (Fullerton, CA, USA).
Western blots
After VSMCs were stimulated with 20 μmol/L of parthenolide in medium containing 10% FBS for 2, 6, 12, and 24 h, cells were harvested and cellular protein was isolated with a protein extraction buffer. Protein concentrations were determined using BioRad DC Protein Assay (Bio-Rad Laboratories, Milan, Italy). Equal amounts (30 g/lane) of proteins were fractionated on 10%~12% (w/v) sodium dodecyl sulfate polyacrylamide gel electropheresis (SDS-PAGE) gels and transferred to polyvinylidene difluoride membranes. The membranes were incubated with anti-IκBα, Cox-2, p21 and p27 primary antibodies (all in 1:400 dilution), respectively, overnight or with anti-actin (1:1000) for 1 h. After washing with PBS containing 0.1% (v/v) Tween 20, the membranes were incubated with corresponding horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies (1:1000) for 1 h, followed by exposure using enhanced chemiluminescent reagent. The images of Western blots were scanned and quantitated using the software Quantity One (Bio-Rad Laboratories). Results were normalized by the respective level of β-actin.
Statistical analysis
Data are presented as mean±SD of three independent experiments. Student's t-test was used to determine the statistical difference between various experimental and control groups. Differences were considered statistically significant at a level of P<0.05.
RESULTS
Identification and characterization of VSMCs
VSMCs isolated by using the explant method in this study grew in the characteristic hill and valley pattern. As shown in Fig.1b , the purity of the VSMCs was determined by immunostaining for monoclonal anti-SM-α-actin. Primary cultures with less than 95% VSMCs were discarded. Cellular viability was determined by cell counting, morphology examinations, and trypan blue exclusion, and the concentrations of parthenolide (10, 20, and 30 μmol/L) used in this study were not toxic to VSMCs.
Effects of parthenolide on DNA synthesis in VSMCs
First, we determined the effect of parthenolide on VSMC proliferation assessed by determination of relative to respective control levels (P<0.05 or P<0.01). Thus, the treatment of parthenolide resulted in significant and dose-dependent inhibition on DNA synthesis in VSMCs cultured under 10% FBS.
Effects of parthenolide on cell cycle progression in VSMCs
Next, we determined the effect of parthenolide on cell cycle progression in VSMCs by flow cytometry. Treatment with 10, 20, and 30 μmol/L parthenolide significantly increased the cell population at G 0 /G 1 phase by 19.2%, 45.3%, and 65.7%, respectively, and decreased the cell population at S phase by 50.7%, 76.2%, and 84.8%, respectively (P<0.05 or P<0.01 compared with the control group) ( Fig.3 and Table 1 ). These results indicate that parthenolide induces cell cycle arrest at G 0 /G 1 phase and decreases the cell population at S phase, which is consistent with the finding that treatment of parthenolide inhibits [ 3 H]thymidine from being incorporated into DNA in VSMCs.
Effects of parthenolide on expression of IκBα, Cox-2, p21 and p27 proteins
To investigate the potential molecular mechanisms that may be involved in the inhibitory effect of parthenolide on VSMCs, we examined several regulatory proteins that are associated with cell proliferation, differentiation, and cell cycle progression, including IκBα, Cox-2, p21 and p27. As shown in Fig.4 , 10% FBS induced degradation of IκBα in the control group at 12 and 24 h of incubation. However, the treatment with 20 μmol/L parthenolide completely blocked the serum-induced IκBα degradation at 12 and 24 h incubation (P<0.01). In contrast, 10% FBS alone induced up-regulation of Cox-2, particularly, at 6 h of incubation, but the presence of parthenolide signifycantly reduced the protein levels of Cox-2 at 2, 6, and 12 h of incubation (P<0.01). Moreover, while there were no remarkable changes on protein levels of p21 and p27 in the control group, the treatment of parthenolide significantly up-regulated both proteins at 12 and 24 h of incubation (P<0.01).
DISCUSSION
Parthenolide is a sesquiterpene lactone found as Table 1 G the major active component in feverfew (Tanacetum parthenium), a herbal medicine that has been used to treat migraine and rheumatoid arthritis for centuries Knight, 1995) . Recently, it has been reported that parthenolide possesses antitumor activity in a number of cultured cancer cell lines and in xenograft models (Oka et al., 2007; Ross et al., 1999) . Moreover, parthenolide has been suggested to protect against myocardial ischemia and reperfusion injury in rats , inhibit the proliferation of vascular endothelial cells (Parada-Turska et al., 2007; Shanmugam et al., 2006) , and inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells (Wong and Menendez, 1999) . Thus, interest has arisen in investigating the potential roles of parthenolide in preventing or treating cardiovascular diseases. In the present study, we evaluated the effects of parthenolide on the proliferation of rat aortic smooth muscle cells. We found that treatment of parthenolide, at non-toxic concentrations between 10~30 μmol/L, significantly suppressed the [ 3 H]thymidine incorporation into DNA by 30.3%~56.1% in a dose-dependent manner (Fig.2) , and increased the cell population at G 0 /G 1 phase while decreased the cell population at S phase (Fig.3) . These results suggest that parthenolide inhibits VSMC proliferation by inducing cell cycle arrest at G 0 /G 1 phase. We further found that parthenolide increased IκBα, p21, and p27, while decreased Cox-2 in VSMCs, providing some clues on the mechanisms of inhibitory effects of parthenolide on VSMC proliferation. Cellular proliferation is regulated primarily by regulation of the cell cycle, which consists of four distinct sequential phases (G 0 /G 1 , S, G 2 , and M). As two important members of Cip/Kip family, p21 and p27 negatively regulate G 1 /S phase and inhibit cell proliferation (Maddika et al., 2007; Hengst and Reed, 1998) . Our results indicate that parthenolide significantly increased the expression levels of both p21 and p27 (Fig.4) , which is consistent with parthenolide-induced inhibition of DNA synthesis and G 0 /G 1 cell cycle arrest in VSMCs.
Although the mechanisms mediating the various effects of parthenolide in different diseases are not entirely clear, several studies have shown that an important part of the anti-inflammatory action of this were fractionated on 10%~12% SDS-PAGE and transferred to polyvinylidene difluoride membranes, followed by immunoblotting with anti-IκBα, Cox-2, p21 and p27 primary antibodies. β-actin protein was blotted as a control (Lane 1: control 2 h; 2: parthenolide 2 h; 3: control 6 h; 4: parthenolide 6 h; 5: control 12 h; 6: parthenolide 12 h; 7: control 24 h; 8: parthenolide 24 h); (b) The quantification of Western blots was done by densitometry and protein levels were expressed as product of OD and area (mm 2 ). Data are the representative of three independent experiments with similar results and are expressed as mean±SD (n=3). compound appears to be related to its activity in inhibiting the NF-κB signal pathway through preventing the degradation of IκBα. NF-κB is a dimeric transcription factor, and genes activated by NF-κB play central roles in cell differentiation, proliferation, inflammation, and apoptosis (Baeuerle and Henkel, 1994; Chen et al., 1999) . This transcription factor is involved in the pathogenesis of many vascular diseases such as atherosclerosis (Collins and Cybulsky, 2001) . IκBα is the specific cytoplasmic inhibitory protein of NF-κB, and degradation of IκBα is generally believed to be the critical step for the activation of NF-κB (Brown et al., 1993) . A recent study indicated that in vascular smooth muscle cells and monocytes stimulated with lipopolysaccharide (LPS), parthenolide reduced IκBα degradation and NF-κB activation (López-Franco et al., 2006) . By Western blots, we observed that 10% FBS induced IκBα  degradation, which may be related to the activation of NF-κB signal pathway and the proliferation of VSMCs stimulated by enriched serum. However, the presence of parthenolide completely antagonized this effect and resulted in upregulation of IκBα protein, which is in agreement with the previous reports showing parthenolide as an inhibitor of NF-κB Sheehan et al., 2002; Hehner et al., 1998; López-Franco et al., 2006) . As an inducible isoform of enzyme, Cox-2 is upregulated in response to inflammatory factors and some peptides (Bishop-Bailey et al., 1999) . Cox-2 metabolites can regulate a number of cellular processes involved in inflammation and remodeling, including the production of chemokines, matrix metalloproteinase, and angiogenic factors (Bishop-Bailey et al., 1999; Marnett et al., 1999; Pang et al., 1998) . Emerging evidence has also shown that Cox-2 enhances VSMC proliferation (Young et al., 2000; Tzeng et al., 2007) . In the present study, we observed that the protein level of Cox-2 was significantly reduced in VSMCs treated with parthenolide for 2~12 h compared with cells cultured with 10% FBS alone (Fig.4) . Recent studies have reported inhibitory effect of parthenolide on Cox-2 expression in monocytic cells and lipopolysaccharide-stimulated macrophages and in cancers (Gomez-Hernandez et al., 2006; Smolinski and Pestka, 2005) . Since the expression of Cox-2 has been shown to be regulated by NF-κB (Dubois et al., 1998; Moon et al., 2004) , our results may suggest that parthenolide upregulates the expression of IκBα protein and subsequently inhibits NF-κB activity, thus reducing the expression of Cox-2 protein. Our results also indicate that NF-κB/ IκBα signaling pathway and Cox-2 are likely involved in the inhibitory effect of parthenolide on VSMC proliferation.
In summary, this study has evaluated the effects of parthenolide on proliferation and cell cycle progression in rat aortic VSMCs in vitro. Our results show that the treatment of parthenolide, in a dosedependent manner, significantly inhibited the proliferation and induced cell cycle arrest at G 0 /G 1 phase in VSMCs, which was supported by the finding that parthenolide significantly increased the protein levels of p21 and p27. Furthermore, parthenolide also significantly increased the protein level of IκBα, while reduced the expression of Cox-2 in a time-dependent manner, suggesting that NF-κB/IκBα signaling pathway may play an important role in this process. Taken together, these findings merit further preclinical studies as well as clinical investigations on the potential therapeutic applications of parthenolide on vascular disorders with overgrowth of VSMCs, such as restenosis and atherosclerosis.
